FrederickL.BaehnerMD
Pathology • San Francisco, CACytopathology, Anatomic Pathology, Clinical Pathology
Chief Medical Officer, Exact Sciences, PO. Associate Professor, University of California, San Francisco
Dr. Baehner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1600 Divisadero St
San Francisco, CA 94143Phone+1 415-353-7043Fax+1 415-353-7676- Is this information wrong?
Education & Training
University of California (San Francisco)Fellowship, Hematopathology, 2002 - 2003- University of California (San Francisco)Fellowship, Cytopathology, 2001 - 2002
- University of California (San Francisco) School of MedicineFellowship, Selective Pathology, 2000 - 2001
- University of California (San Francisco)Residency, Pathology-Anatomic and Clinical, 1997 - 2001
University of Kansas School of MedicineClass of 1997
Certifications & Licensure
CA State Medical License 1999 - 2025
FL State Medical License 2012 - 2014- American Board of Pathology Anatomic Pathology & Clinical Pathology
- American Board of Pathology Cytopathology
Publications & Presentations
PubMed
- BRCA1/2 mutation carriers vs the general breast cancer population (N = 799,986): 21-gene assay-based molecular characterization.Rinat Yerushalmi, Adi Pomerantz, Ron Lewin, Shani Paluch-Shimon, Lior Soussan-Gutman, Hillary Voet, Avital Bareket-Samish, Inbal Kedar, Yael Goldberg, Tamar Peretz-Yab...> ;Breast Cancer Research and Treatment. 2024 Apr 3
- 1 citationsGene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor-Positive Breast Cancer.Soonmyung Paik, Gong Tang, Steven Shak, Chungyeul Kim, Joffre Baker, Wanseop Kim, Maureen Cronin, Frederick L Baehner, Drew Watson, John Bryant, Joseph P Costantino, C...> ;Journal of Clinical Oncology. 2023 Jul 10
- 2 citationsUltrasensitive Circulating Tumor DNA Pilot Study Distinguishes Complete Response and Partial Response With Immunotherapy in Patients With Metastatic Renal Cell Carcinoma.Alexander Chehrazi-Raffle, Ramya Muddasani, Nazli Dizman, JoAnn Hsu, Luis Meza, Zeynep B Zengin, Jasnoor Malhotra, Neal Chawla, Tanya Dorff, Tania Contente-Cuomo, Devi...> ;JCO Precision Oncology. 2023 Apr 1
- Join now to see all
Journal Articles
- 21-Gene Assay as Predictor of Chemotherapy Benefit in HER2-Negative Breast CancerEleftherios P Mamounas, Frederick L Baehner, Norman Wolmark, D Lawrence Wickerham, Nature
- Author Correction: Breast-Cancer-Specific Mortality in Patients Treated Based on the 21-Gene Assay: A SEER Population-Based StudyAnn G Schwartz, Charles F Lynch, Frederick L Baehner, Nature
Professional Memberships
- Member
Other Languages
- Spanish
Hospital Affiliations
UCSF Medical CenterSan Francisco, California
Zuckerberg San Francisco General Hospital and Trauma CenterSan Francisco, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
